Early prediction of treatment outcomes in RA clinical trials is critical for both patient safety and trial success. We hypothesize that an approach employing metadata of clinical trials could provide accurate classification of primary outcomes before trial implementation. We retrieved RA clinical trials metadata from ClinicalTrials.gov. Four quantitative outcome measures that are frequently used in RA trials, i.e., ACR20, DAS28, and AE/SAE, were the classification targets in the model. Classification rules were applied to make the prediction and were evaluated. The results confirmed our hypothesis. We concluded that the metadata in clinical trials could be used to make early prediction of the study outcomes with acceptable accuracy.
['Yuanyuan Feng', 'Vandana Pursnani Janeja', 'Yelena Yesha', 'Naphtali Rishe', 'Michael A. Grasso', 'Amanda Niskar']
Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata